Petrin Christine, Kahan Scott, Turner M, Gallagher C, Dietz W H
George Washington University Washington DC USA.
Obes Sci Pract. 2016 Sep;2(3):266-271. doi: 10.1002/osp4.53. Epub 2016 Jul 7.
Rates of obesity pharmacotherapy use, bariatric surgery and intensive behavioural counselling have been extremely low.
The primary objective of this study was to survey healthcare provider beliefs, practice and knowledge regarding obesity management.
Primary care physicians (PCPs), OB-GYN physicians and nurse practitioners (NPs) responded to a web-based survey related to drug therapy practice, bariatric surgery referral and reimbursement coding practice.
Rates of reported use of obesity pharmacotherapy appear to be increasing among PCPs, which is likely related to the approval of four new obesity pharmacotherapy agents since 2012. Rates of pharmacotherapy use among OB-GYNs and NPs appear much lower. Similarly, few PCPs are averse to recommending bariatric surgery, but aversion among OB-GYNs and NPs is significantly higher.
Together, these observations suggest that OB-GYN and NP populations are important targets for education about obesity management. Very few PCPs, OB-GYNs or NPs use behavioural counselling coding for obesity. Better understanding of why this benefit is not being fully used could inform outreach to improve counselling rates.
肥胖症药物治疗、减肥手术和强化行为咨询的使用率一直极低。
本研究的主要目的是调查医疗服务提供者关于肥胖症管理的信念、实践和知识。
初级保健医生(PCP)、妇产科医生和执业护士(NP)对一项基于网络的调查做出回应,该调查涉及药物治疗实践、减肥手术转诊和报销编码实践。
自2012年以来,随着四种新型肥胖症药物治疗药物获批,初级保健医生报告的肥胖症药物治疗使用率似乎在上升。妇产科医生和执业护士的药物治疗使用率似乎低得多。同样,很少有初级保健医生反对推荐减肥手术,但妇产科医生和执业护士中的反对率明显更高。
综合来看,这些观察结果表明,妇产科医生和执业护士群体是肥胖症管理教育的重要目标人群。很少有初级保健医生、妇产科医生或执业护士使用肥胖症行为咨询编码。更好地理解为何这一益处未得到充分利用,可为提高咨询率的推广工作提供信息。